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Objectives: The purpose of this study was to analyze the mechanisms 
associated with lung injury after cardiopulmonary b pass and to propose 
strategies of prevention. Methods: Thirty-two neonatal piglets underwent 90 
minutes of hypothermic ardiopulmonary bypass without aortic cross- 
clamping. Five experimental groups were defined: group I had standard 
cardiopulmonary b pass (control), group II received continuous low-flow 
lung perfusion during cardiopulmonary b pass, group II I  treatment was 
similar to that of group I with maintenance ofventilation, group IV received 
pneumoplegia, nd group V received nitric oxide ventilation (30 ppm) after 
cardiopulmonary b pass. Data drawn from hemodynamic and gas exchange 
values and muscular and pulmonary tissular levels of adenosine triphos- 
phate (in micromoles per gram) and myeloperoxidase (in international 
units per 100 rag) were used for comparisons before and 30 and 60 minutes 
after cardiopulmonary b pass. Pulmonary and systemic vascular endothe- 
lial functions were assessed in vitro after cardiopulmonary bypass on 
isolated rings of pulmonary and iliac arteries. Results: Pulmonary vascular 
resistance index, cardiac index, and oxygen tension were better preserved in 
groups II, IV, and V. All groups disclosed a significant decrease in lung 
adenosine triphosphate l vels and an increase in myeloperoxidase activity 
whereas these levels stayed within pre-cardiopulmonary bypass ranges in 
muscular beds. Endothelium-dependent relaxation was preserved in sys- 
temic arteries but was strongly affected in pulmonary arteries after 
cardiopulmonary b pass. None of the methods that aimed to protect he 
pulmonary vascular bed demonstrated any preservation of pulmonary 
endothelial function. Conclusion: Cardiopulmonary b pass results in isch- 
emia-reperfusion injury of the pulmonary vascular bed. Lung protection by 
continuous perfusion, pneumoplegia, or nitric oxide ventilation can prevent 
hemodynamic alterations after cardiopulmonary bypass but failed to 
prevent any of the biochemical disturbances. (J Thorac Cardiovasc Surg 
1997;114:1061-9) 
C ardiac operations for repair of acquired or con- genital heart defects mandate in the vast major- 
ity of cases the use of cardiopulmonary bypass 
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(CPB). In the early days of CPB, pulmonary com- 
plications caused a significant percentage of the 
cases of morbidity and mortality. 1 In the past de- 
cades, during which time CPB has become common- 
place, improvements in technology and better un- 
derstanding of the physiopathologic processes of 
lung injury after these procedures have reduced the 
incidence of pulmonary complications, but they still 
remain a problem. Acute pulmonary hypertension 
with decreased gas exchange and low cardiac output 
are not uncommon, and microscopic alterations of 
the lung parenchyma have been demonstrated. 2 
Since the initial work of Chenoweth and colleagues, 3 
who demonstrated the release of complement-de- 
rived anaphylatoxins C3a and C5b during and after 
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CPB, literature on the inflammatory response 
caused by CPB has been extensive and a number of 
cytokines have been addressed and demonstrated to
take part in the post-CPB inflammatory syndrome. 4 
Recent advances have made neonatal complete 
repair for many congenital heart defects safer than 
ever before. However, the neonatal immature lung 
presents several particularities that make it more 
vulnerable to CPB, and a higher rate of pulmonary 
complications have been reported in these neonates 
than in an adult popu!ation. 5 
During total CPB, pulmonary blood flow is com- 
pletely shut off and the lungs are perfused by 
bronchial flow alone, putting the lungs at risk for an 
ischemic insult and reperfusion injury when normal 
antegrade flow is reestablished through the pulmo- 
nary artery after CPB. On the other hand, CPB has 
been demonstrated to induce inflammatory humoral 
cascades and cellular activation, which lead to tissue 
injury. 
The primary goa ! of this study was to investigate 
the biochemical and hemodynamic variations occur- 
ring in the pulmonary vascular bed after total CPB 
in neonatal piglets. A further objective of this work 
was to define whether prevention of these variations 
is feasible. 
Material and methods 
Thirty-two neonatal piglets (mean age 7 days, mean 
weight 3.2 kg) were purchased from a local farmer. All 
animals received humane care in compliance with the 
=Principles of Laboratory Animal Care" formulated by 
the National Society for Medical Research and the 
"'Guide for the Care and Use of Laboratory Animals" 
published by the National Institutes of Health (NIH 
Publication No. 85-23, revised 1985). The piglets were 
fasted for 12 hours before the operation, sedated with 
intramuscular ketamine (250 mg), and anesthetized with 
pentobarbital sodium (15 mg/kg intravenously). Subse- 
quently, the animals were intubated and general anesthe- 
sia was maintained with N20 (60%)/02 (40%) with inter- 
mittent positive ventilation pressure (MMS 107 ventilator, 
Paris) at 40 breaths min with a tidal volume of 15 ml/kg. 
With the piglets in a supine position, the femoral vessels 
were isolated on each side. After femoral arterial cannu- 
lation, ventilatory rate and tidal volume were adjusted to 
establish a normal pH and carbon dioxide tension as 
determined by arterial blood gas determination (ABL2, 
Radiometer, Copenhagen). The contralateral superficial 
femoral artery was isolated and harvested for pre-CPB 
systemic endothelial function assessment in vitro. After 
completion of a midline sternotomy and pericardiotomy, 
the ductus was ligated and the great vessels were con- 
trolled. A pulmonary artery catheter (Intracath) was 
introduced into the main pulmonary artery through the 
right ventricular infundibulum and cardiac output was 
recorded with use of a Doppler probe placed around the 
pulmonary artery trunk (model T106 M, Transonic Sys- 
tems). The central venous pressure and the left atrial 
pressure were monitored after placement of indwelling 
catheters in the right and left atrium. Pressure recording 
was performed with a P23 ID Statham pressure trans- 
ducer. 
After heparin administration (3 mg/kg), CPB was insti- 
tuted from the right atrium with the arterial return 
directed into the ascending aorta. The bypass circuit 
Consisted of a cardiotomy reservoir and a membrane 
oxygenator (Dideco), a heat exchanger, and a roller pump. 
No arterial filter was used. The circuit was primed (400 
ml) with whole blood obtained from a donor pig the day 
before the operation. Within the first 5 minutes of CPB, a 
vent was introduced through the left Ventricular apex. 
Mean systemic arterial pressure was maintained at preby- 
pass values with a mean flow rate of 500 ml/min. After a 
steady state under CPB was obtained, ventilation was 
stopped and cooling to 28 ° C was started. The pulmonary 
artery trunk was crossclamped to prevent any antegrade 
flow to the lungs while CPB was maintained for 90 
minutes without aortic crossclamping. During CPB pul- 
monary blood flow was measured by collecting the blood 
that drained from the left ventricle. After this period 
mechanical ventilation was reinstituted and the piglets 
were weaned from CPB. After 1 hour of survival, they 
were killed. The pulmonary arterial vessels were dissected 
beyond the second-generation branch and mounted in an 
organ chamber for vascular eactivity evaluation. In addi- 
tion, systemic vessels from the iliac artery were dissected 
free and mounted in an organ chamber for vascular 
physiologic studies. 
Physiologic measurements. Hemodynamic measure- 
ments were made before institution of CPB and every 30 
minutes after cessation of CPB. Cardiac output was 
determined as pulmonary blood flow (Qpa in liters per 
minute), cardiac index (CI), systemic vascular esistance 
index (SVRI), and pulmonary vascular esistance index 
(PVRI) were calculated as follows: 
CI = Qpa/Body weight (kg) 
SVRI (dyne • sec -1 • cm -5 • kg) 
= (MAP-RAP)/CI • 79.9 
PVRI (dyne • sec -1 , cm -5 • kg) 
= (PAP-LAP)/CI • 79.9 
where MAP is the mean systemic arterial pressure, RAP 
the mean right atrial pressure, PAP the mean pulmonary 
arterial pressure, and LAP the mean left atrial pressure. 
Throughout he ~ experiment, central, myocardial, and 
lung temperatures were monitored. Biopsy specimens 
were obtained before and 30 and 60 minutes after CPB for 
adenosine triphosphate (ATP), lactate, and myeloperoxi- 
dase (MPO) measurements from lung and skeletal muscle 
tissues. 
Evaluation of pulmonary energy metabolism 
ATP and lactate measurements. All biopsy specimens of 
fresh tissues were immediately frozen at a depth of 1 mm 
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with metal tongs chilled in liquid nitrogen. Once frozen, 
the tissues were stored at -80 ° C. ATP and lactate mea- 
surements were performed according to the methods 
described by Date and associates. 6 The specimens were 
pulverized in liquid nitrogen and metabolites were ex- 
tracted in perchloric acid 0.6 N. After centrifugation and 
neutralization, the supernatants were analyzed for metab- 
olites by the enzymatic methods of Lowry and Passon- 
neau. 7Data are given as micromoles per gram of frozen 
tissue. 
Evaluation of pulmonary leukocyte sequestration. 
Blood samples were drawn from the pulmonary artery 
catheter and left atrial line for total and differential 
(neutrophils) white blood cell counts (Argos 3, ABX 
France, Montpellier) before the start of CPB, at the time 
of pulmonary reperfusion, and 30 and 60 minutes after the 
discontinuation of CPB. The percentage of pulmonary 
leukosequestration was expressed as the difference be- 
tween the pulmonary artery and left atrial white blood cell 
count divided by the pulmonary artery White blood cell 
count all multiplied by 100. 
MPO activity. The method described by Mullane, Krae- 
met, and Smith 8 was used to measure MPO activity in the 
lungs. Before and 30 and 60 minutes after CPB, biopsy 
samples were frozen in liquid nitrogen and stored at 
-80 ° C. They were then pulverized and homogenized in 
10% wt/vol hexadecyltrimethyl ammonium bromide buffer 
(0.5% hexadecyltrimethyl ammonium bromide in 50 
mmol/L phosphate buffer at pH 6.0) with a Polytron 
homogenizer. The homogenate was sonicated on ice for 
15 seconds, frozen at -70 ° C, and thawed three times, then 
centrifuged at 40,000g for 15 minutes. Supernatant was 
assayed for MPO activity spectrophotometrically. Twenty 
microliters of supernatant was combined with 12/xl of 25 
mm H202, 30/xl of 40 mmol/L O-dianisidine hydrochlo- 
ride, and 1.938 ml of 50 mmol/L phosphate buffer (pH 
6.0). The change in absorbance was measured at 460 nm 
on a Beckman spectrometer (model 25). One unit of MPO 
activity was defined as the activity degrading 1 txmol of 
peroxide per minute at 25 ° C. 
Isolated pulmonary arterial ring studies. At the end of 
each experiment, left and righ t intrapulmonary arterial 
segments were dissected out and placed in warm Krebs- 
Henseleit buffer composed of (in micromoles per liter) 
118.3 NaC1, 4.7 KC1, 2.5 CaC12.2H20, 1.2 KH2PO4, 1.2 
MgSO4.7H20, 25 NaHCO3, 0.03 ethylenediaminetet- 
raacetic acid, and 11.1 glucose. Isolated pulmonary arter- 
ies were cleaned and cut into rings 3 to 4 mm in length (1 
to 2 mm outer diameter). Three to four rings were 
obtained from each animal. The rings were then mounted 
on stainless teel hooks, suspended in 10 ml tissue baths, 
and connected to force displacement transducers (LB-5, 
Showa-sokki) to record changes in force by the use of a 
chart recorder (LR 4210, Yokogawa). The baths were 
filled with 10 ml of Krebs-Henseleit buffer and aerated at 
37°C with a gas mixture of 95% 0 2 and 5% CO2. 
Pulmonary arterial rings were initially stretched to pro- 
duce a preload of lg of force and equilibrated for 60 to 90 
minutes. A preload of lg has been proved to be the 
optimal resting tension on the basis of length tension 
analyses performed in pilot studies. This value is close to 
the optimal resting tension (1.060 _+ 0.040g) found by Liu 
and associates 9 in piglet neonatal pulmonary arterial 
rings. During this period, the Krebs-Henseleit buffer in 
the tissue baths was replaced every 10 minutes. After 
incubation with iradomethacin (10 -5 mo!/L) for 60 min- 
utes, a concentration-response curve to phenylephrine 
was obtained. The rings were then washed, and the 
developed force was allowed to return to the baseline 
level. The rings were then precontracted with phenyleph- 
rine to generate about lg of developed force. Once a 
stable contraction was obtained, cumulative doses of 
acetylcholine (10 -9 to 10 .3 mol/L) were added to the bath 
to assess changes in endothelium-dependent relaxation. 
These rings were washed again and allowed to equilibrate 
to baseline levels. The procedure was repeated with a 
single dose (10 .5 mol/L) of sodium nitroprusside, an 
endothelium-independent vasodilator. 
In addition to the change in force, responses were 
assessed by determination of the concentration that pro- 
duced 50% of the maximal response (ECso) extrapolated 
from a plot of log concentration versus percentage of 
maximal response. The contractile responses to phenyl- 
ephrine were expressed in absolute values (milligrams) 
and the maximum relaxation to acetylcholine and sodium 
nitroprusside was expressed as the percentage of the 
phenylephrine-induced precontraction: 0% indicates no 
relaxation and 100% a relaxation that equals the magni- 
tude of the precontraction. 
Pulmonary arterial rings obtained after CPB were com- 
pared with control pulmonary artery rings obtained from 
matched piglets that did not undergo CPB. 
Groups. Five groups were studied, Group I (n = 7) was 
a control group in which no intervention was made to 
protect the lungs during CPB. In group II (n = 7) the 
pulmonary vascular bed was perfused (mean flow 35 
ml/min, mean perfusion pressure 14 mm Hg) with venous 
blood during CPB with an independent pump. In group 
III (n = 6) the ventilation was maintained uring CPB. In 
group IV (n = 6) Cambridge pneumoplegic solution was 
administered during CPB at crossclamping of the pulmo- 
nary artery, and in group V (n = 6) the piglet lungs were 
ventilated with nitric oxide (NO; 30 ppm) at the time of 
pulmonary reperfusion. 
Drugs. The following drugs were used (Sigma Chemi- 
cal): indomethacin, phenylephrine, acetylcholine, and so- 
dium nitroprusside. All drugs were freshly prepared on 
the day of the experiment. 
Statistical analysis. All results are expressed as mean 
plus or minus the standard error of the mean. Intergroup 
and intragroup mean values were compared by two-way 
analysis of variance to analyze the combined effect of time 
and group. The Newman-Keuls multiple-sample compar- 
ison test was used to evaluate any differences in the 
results. 
Results 
Hemodynamic results (Fig. 1). Pulmonary venous 
return dra ined to the reservoir was reduced to a 
mean of  0.5% of bypass flow. This was only in- 
creased to a mean of 15% in group II. The systemic 
vascular resistance index increased in all groups 
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Fig. 1. A, Variations in the systemic vascular esistance index. B, Variations in the pulmonary vascular 
resistance index. C, Variations in the cardiac index. D, Variations in the oxygen tension values, tO, Before 
CPB; tl, 30 minutes after weaning from CPB; t2, 60 minutes after weaning from CPB. The groups are those 
described in the text. *p = 0.001 versus tO. 
Group I
Group II 
Group Ill 
Group IV 
Group V 
after 90 minutes of hypothermic CPB without cross- 
clamping of the aorta but this reached statistical 
significance only in groups I and III. 
Pulmonary vascular esistance values and pulmo- 
nary vascular resistance index were significantly 
increased after CPB in groups I and III. Lung 
protection by continuous lung perfusion, by pneu- 
moplegia, or by NO ventilation at the time of 
pulmonary reperfusion seems to prevent the in- 
crease in pulmonary vascular esistance and pulmo- 
nary Vascular esistance index. 
Cardiac outpu t and cardiac index were better 
preserved in groups IV and V at 30 and 60 minutes 
after the cessation of bypass. Although both cardiac 
output and cardiac index were initially (a t 30 rain- 
utes) well preserved in group II, they demonstrated 
a significant trend to decrease 1hour after CPB. On 
the other hand, groups ! and III showed a severe 
reduction of cardiac output and cardiac index after 
bypass and inotropic support was necessary in four 
of the piglets to maintain survival. 
Oxygen delivery was also significantly affected in 
groups I and III. 
Pu lmonary  energy metabo l i sm (Fig. 2). All 
groups showed a significant decrease in pulmonary 
parenchymal ATP stores. However, groups I and III 
had the lowest levels at 30 minutes after the cessa- 
tion of bypass, which then plateaued until the ani- 
mals were killed. On the other hand, groups II, IV, 
and V demonstrated better preservation of ATP 
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Fig. 3. Variations in the lung MPO activity before (TO) CPB and 30 minutes (7"1) and 60 minutes (T2) 
after weaning from CPB. The groups are those described in the text. *p = 0.001 versus TO. 
stores at 30 minutes after bypass, which continued to 
decrease at 60 minutes. In this model, muscular 
ATP stores were preserved to pre-CPB levels 
throughout the experimental procedure (1.33 + 0.13 
/xmol/gm fresh tissue before bypass vs 1.32 ± 0.12 
/xmol/gm fresh tissue 60 minutes after weaning from 
bypass). 
The inverse profile was observed with lactate accu- 
mulation in lung parenchyma (1.76 ± 0.28/xmol/gm 
fresh tissue before bypass vs 5 ± 0.8/xmol/grn fresh 
tissue 60 minutes after cessation of bypass). 
MPO activity and pulmonary leukocyte seques- 
tration (Figs. 3 and 4). MPO activity was signifi- 
cantly increased in all groups at 60 minutes after 
bypass; however, this increase was delayed in groups 
I, II, and V. Neutrophil sequestration i the lung 
parenchyma after CPB was significantly increased at 
30 and 60 minutes after bypass only in group V. 
Throughout the experimental procedure and in all 
groups, MPO activity in skeletal muscle could not be 
detected either before CPB or 60 minutes after 
cessation of bypass. 
Isolated pulmonary and femoral arterial ring 
study (Figs. 5 and 6). In pulmonary vessels, similar 
maximal contraction to phenylephrine was observed 
in all groups. The ECs0 to phenylephrine in each 
group was not different from that in control animals 
not subjected to CPB. 
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Fig. 5. Endothelium-dependent relaxation in pulmonary vessels. The vessels were precontracted with 
phenylephrine and cumulative doses of acetylcholine were added to the bath. The groups are those 
described in the text. *p = 0.01 versus Control No CPB. 
The maximal relaxant response to acetylcholine 
obtained in all groups was reduced to 50% of 
control values. The ECso for acetylcholine was 
nearly unchanged in all groups and ranged from 8.5 
• 10 .8 to 1.8 • 10 -7 mol/L. These results indicate that 
after CPB endothelium-dependent relaxation of 
pulmonary artery was impaired. Conversely, the 
response to sodium nitroprusside was not altered 
after CPB and ranged from 10% to 120%. 
In contrast to the results obtained with pulmonary 
arterial rings, the endothelium-dependent relax- 
ation measured in systemic vessels was not altered 
after total CPB. 
Discuss ion  
This study confirms the observation of previous 
works that during total CPB the pulmonary bed is 
subjected to an ischemia-reperfusion injury that 
leads to a decrease in the energy stores of the lung 
parenchyma. 1°-14 Interesting enough was the failure 
of general hypothermia to 28 ° C to prevent he loss 
of ATP and the accumulation of lactates in lungs 
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tissue, whereas these stayed within control values in 
territories not subjected to ischemic injury. 
Neutrophil involvement in the pathophysiologic 
processes of the pulmonary vascular injury after 
CPB is a well-described phenomenon. 15-2° However, 
in the present study, the lungs only showed ysfunc- 
tion whereas the systemic vascular beds, which did 
not undergo ischemia-reperfusion njury, did not 
present hemodynamic mpairment, leukocyte se- 
questration, or endothelial dysfunction. These re- 
sults tend to demonstrate hat vascular tissue injury 
occurs when both endothelial injury and neutrophil 
activation are present. Activated neutrophils alone 
or associated with plasmatic inflammatory cyto- 
kines, which are known to be released uring CPB, 
failed in the present study to cause peripheral 
vascular tissue injury because MPO activity and 
endothelial control of vascular tone were preserved 
in those territories. 
Another consequence of CPB was the loss of 
vascular tone control by pulmonary artery endothe- 
lial cells. This has been already reported in experi- 
mental models 14'21-23 and in patients. 24 Several 
hypotheses have been proposed to explain this phe- 
nomenon. Some reports imply the role of a systemic 
inflammation reaction including free radicals from 
activated neutrophils 17and thromboxane A2.11' 25, 26 
More recently, Morita and coworkers 23 have shown 
a protective ffect of the pulmonary endothelium 
after CPB by the use of antioxidant agents arguing 
that hydrogen peroxide and the subsequent produc- 
tion of hydroxyl radical is a strong effector of 
endothelial damage. Finally, another hypothesis ad- 
vanced to explain the mechanism of pulmonary 
endothelial dysfunction after CPB is the existence of 
an ischemic insult to the endothelial cells. Previous 
studies on cultured endothelial cells submitted to 
various durations of hypoxia showed a significant 
deficiency of intracellular high-energy phos- 
phates27, 28 and the cells lost their capacity to con- 
tract. 29 In addition, reoxygenation is likely to pro- 
duce a lipid peroxidation with membrane damage 
and production of reactive 0 2 species) ° Addition- 
ally, previous work from our laboratory has shown in 
an isolated perfused lung model that ischemia lone 
is responsible for a loss of endothelial pulmonary 
vascular tone control, which was even amplified by 
reperfusion. 31 
We can therefore speculate that when endothelial 
cells are subjected to an ischemic insult there is a 
significant loss of intracellular high-energy phos- 
phates with a parallel activation of glycolysis as 
evidenced by increased lactate production. Endo- 
thelial cells then express surface antigens that are 
targets for activated neutrophils. The latter adhere 
at reperfusion on the endothelium and produce a 
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toxic amount of cytotoxic enzymes that induce tissue 
destruction. 
On the assumption that lung ischemia-reperfu- 
sion syndrome was the main cause of the endothelial 
dysfunction observed in pulmonary arteries and that 
activated neutrophils mandate an endothelial injury 
to further exert detrimental effects on vascular 
tissues, we attempted to avoid lung ischemia-reper- 
fusion injury by several methods. Reduction of 
energy demand was achieved by general hypother- 
mia, which alone failed to protect he pulmonary 
vascular bed (group I). Provision of energy sub- 
strates to the lungs during CPB was achieved either 
by continuous lung perfusion (group II) or by ven- 
tilation (group III). Pneumoplegia (group IV) was 
performed because of the similitude that may exist 
with lung transplantation, and, finally, post-CPB 
ventilation with NO (group V) was used because 
NO has been demonstrated to avoid neutrophil lung 
sequestration a d to reduce reperfusion i jury after 
lung ischemia nd reperfusion i  neonates) 2 
Although the post-CPB hemodynamic status was 
better preserved when the lungs were protected by 
continuous perfusion, pneumoplegia, or inhalation 
of NO at reperfusion, there were no significant 
differences among the five groups in the values 
reflecting the lung energy metabolism, neutrophil 
lung sequestration, or capacity of the pulmonary 
arterial rings to relax to an endothelium-dependent 
agonist. However, groups that received lung protec- 
tion by continuous perfusion, pneumoplegia, or NO 
at reperfusion demonstrated a better initial conser- 
vation of high-energy phosphates, which secondarily 
decreased with time. The absence of a correlation 
between post-CPB hemodynamic status and biologic 
results might be explained by several hypotheses. 
Continuous lung perfusion in the present model was 
performed under suboptimal and nonphysiologic 
conditions, with a low, nonpulsatile flow, and prob- 
ably resulted in nonperfused areas. In this group, to 
maintain a determined rate of flow, we adapted the 
flow to the pulmonary arterial pressure kept at 
about 15 mm Hg. This pressure level was achieved 
with a suboptimal flow rate of 35 ml/kg per minute. 
Any increase in flow rate was associated with an 
extraphysiologic in rease in pulmonary arterial pres- 
sure. The reasons for such reaction, although un- 
clear, could be explained by the facts that during 
operations with an open thorax lung compliance is
modified and that hypothermia per se may lead to 
pulmonary vasoconstriction. In addition, pneu- 
moplegia was not repeated uring CPB and the 
solution was quickly washed out by the collateral 
flow from the bronchial arteries; therefore its ben- 
eficial effects, if any, were only transient. 
The most surprising results were obtained with 
NO inhalation at lung reperfusion and after cessa- 
tion of CPB. In a model of isolated neonatal lung 
ischemia and reperfusion, NO provided at lung 
reperfusion was able to prevent reperfusion injury 
with conservation fpulmonary endothelial function 
and an absence of neutrophil sequestration. 32 In the 
present model, NO inhalation at the end of CPB was 
associated with the highest rate of lung neutrophil 
sequestration a d failed to provide protection of the 
pulmonary endothelium. Several methodologic fac- 
tors between isolated lung perfusion and CPB might 
explain these different results: (1) in CPB, the 
bronchial circulation although minimal is still patent 
and can provide to the ischemic endothelial cells 
circulating activated neutrophils and cytokines and 
(2) innervation is maintained intact during CPB and 
might have physiologic implications for the pulmo- 
nary microcirculation with vasoconstriction and 
neutrophil entrapment. This paradoxic effect of NO 
has been previously documented 33 and was sup- 
ported by the evidence of interaction between NO 
and superoxide, which can combine to form per- 
oxynitrite anion, which can generate hydroxyl anion, 
both of which are potent oxidizing components. 
In conclusion, neonatal CPB leads to severe isch- 
emic damage of the pulmonary vascular endothe- 
lium, which then interacts with activated neutrophils 
at reperfusion. More refined cellular and subcellular 
experimentation seems necessary to determine the 
different sequences of cellular damage and then to 
propose preventive therapy. Among the different 
methods that aim to protect he lungs during CPB, 
continuous lung perfusion, pneumoplegia, nd NO 
ventilation at lung reperfusion prevent more severe 
hemodynamic deterioration. 
We are grateful to Chantal Verriest, Mich6le Galliard, 
Rdmi Burel, H6g6sippe Langouste, and Pascal Gusmini 
for their technical ssistance. 
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